VolitionRx shareholders approve 75% increase in authorized shares to 175M and new equity plan

VOLITIONRX LTD

Authorized shares increased from 100M to 175M (75% increase), effective July 2, 2024 via Certificate of Amendment.
2024 Stock Incentive Plan adopted, reserving 7.5M shares for future equity awards to employees, directors, and consultants.
Six director nominees elected; auditor Sadler, Gibb & Associates ratified; say-on-pay advisory vote passed.
All five stockholder proposals at annual meeting passed; 49.0M of 82.8M shares outstanding were voted.
Both the share increase and equity plan were stockholder-approved and immediately effective.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.